Statements (82)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Tricell
|
| gptkbp:acquired |
Umbrella Corporation assets
|
| gptkbp:competes_with |
gptkb:lake
|
| gptkbp:controversy |
Environmental impact
Sustainability issues Ethical dilemmas Legal challenges Financial risks Safety issues Operational risks Regulatory violations Compliance risks Intellectual property disputes Ethical risks Investment risks Public health concerns Strategic risks Corporate governance issues Economic sustainability issues Human experimentation Corporate espionage Market risks Regulatory risks Reputational risks Crisis management issues Public relations challenges Transparency issues Litigation risks Financial sustainability issues Accountability issues Profit motives Consumer trust issues Environmental sustainability issues Social responsibility issues Market competition issues Stakeholder engagement issues Compliance sustainability issues Corporate social responsibility issues Cultural sustainability issues Ethical sustainability issues Investment sustainability issues Legal sustainability issues Market sustainability issues Operational sustainability issues Political sustainability issues Regulatory sustainability issues Reputation management issues Reputational sustainability issues Social sustainability issues Stakeholder conflicts Strategic sustainability issues Technological sustainability issues |
| gptkbp:develops |
Pharmaceutical products
|
| gptkbp:employs |
gptkb:physicist
|
| gptkbp:facilities |
gptkb:Raccoon_City_Laboratory
|
| gptkbp:founded |
gptkb:2000
|
| gptkbp:headquarters |
gptkb:Raccoon_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tricell Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investment |
Biotechnology companies
|
| gptkbp:is_divided_into |
Bioweapons Division
|
| gptkbp:is_involved_in |
gptkb:Raccoon_City_incident
Ethical controversies |
| gptkbp:key_people |
gptkb:Albert_Wesker
|
| gptkbp:known_for |
T-Virus research
|
| gptkbp:operates_in |
gptkb:United_States
|
| gptkbp:part_of |
gptkb:Resident_Evil_series
|
| gptkbp:partnerships |
Government agencies
Research institutions Private sector companies Various military organizations |
| gptkbp:product_line |
Antibiotics
Vaccines Diagnostics Antivirals Therapeutics |
| gptkbp:products |
Bioweapons
|
| gptkbp:reputation |
gptkb:Controversial_practices
|
| gptkbp:research_focus |
Genetic engineering
|
| gptkbp:subsidiary |
gptkb:Tricell,_Inc.
|